Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study
Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study. desensitized after OIT, with nine achieving SU after discontinuing OIT for four weeks. Basophil hyporesponsiveness, defined by lower CD63 expression, was detected…